Imaging News and Research

RSS

Experts propose three areas that must be considered when resuming cardiovascular procedures

The American College of Cardiology together with other North American cardiovascular societies has issued a framework for ethically and safely reintroducing invasive cardiovascular procedures and diagnostic tests after the initial peak of the COVID-19 pandemic.

5 May 2020

A systematic framework to reintroduce cardiovascular diagnosis and treatment care during COVID-19

The American Heart Association, together with 14 cardiovascular societies in North America, today issued joint guidance, "Safe Reintroduction of Cardiovascular Services during the COVID-19 Pandemic: Guidance from North American Society Leadership," to outline a systematic, phased approach to safely reintroducing cardiovascular procedures for diagnosis and treatment during the COVID-19 pandemic.

5 May 2020

New technology enables visualization of small structures inside whole cells and tissues

Since Robert Hooke's first description of a cell in Micrographia 350 years ago, microscopy has played an important role in understanding the rules of life.

4 May 2020

Researchers develop AI algorithm to accurately predict risk for and diagnose Alzheimer's

Researchers have developed a computer algorithm based on Artificial Intelligence that can accurately predict the risk for and diagnose Alzheimer's disease using a combination of brain magnetic resonance imaging, testing to measure cognitive impairment, along with data on age and gender.

4 May 2020

AI-based technology could help accelerate clinical trials for glaucoma

The technology, supported by an artificial intelligence (AI) algorithm, could help accelerate clinical trials, and eventually may be used in detection and diagnostics, according to the Wellcome-funded study published today in Expert Review of Molecular Diagnostics.

4 May 2020

Using photoacoustic imaging to visualize scarring in donor kidneys before transplant

When kidney transplants first came into practice in the 1950s, patients with chronic kidney disease could finally picture freedom from the unrelenting routine of blood-cleansing dialysis treatments. Just over a half-century later, demand has completely outstripped supply.

2 May 2020

Using Multiplex Assays to Discover Biomarkers for Parkinson’s Disease

In this interview, Dr. Polinski and Dr. Atabakhsh discuss the importance of developing biomarkers for Parkinson’s and the partnership between MJFF and Abcam.

From Abcam 1 May 2020

Multicolor Immunohistochemistry (IHC): Going Beyond a Single Color

An interview with Dr. Will Howat at SfN 2018, discussing the possibilities and challenges of immunohistochemistry (IHC) beyond a single color!

From Abcam 1 May 2020

New math model predicts clinical outcomes in cancer patients treated with immunotherapy

A group of our cancer and mathematics researchers at Houston Methodist have developed a clinically-applicable mathematical model to predict patient outcomes to cancer immunotherapy.

30 Apr 2020

Nanodevices could prevent plaque formation in the brain

Alzheimer's disease is the sixth leading cause of death in the United States, affecting one in 10 people over the age of 65. Scientists are engineering nanodevices to disrupt processes in the brain that lead to the disease.

30 Apr 2020

HORIBA Medical and CellaVision collaborate on new automated Digital Cell Morphology solution to enhance lab workflows

HORIBA UK Ltd, Medical has introduced a new automated digital cell morphology solution in collaboration with CellaVision to help hematology laboratories.

From HORIBA Medical 30 Apr 2020

WITec reveals new generation alpha300 apyron

WITec GmbH, pioneer of Raman imaging and correlative microscopy, establishes the next level of automation and user-friendliness with the introduction of the new alpha300 apyron.

From WITec GmbH 30 Apr 2020

NIH announces new initiative to speed up COVID-19 testing technologies

The National Institutes of Health today announced a new initiative aimed at speeding innovation, development and commercialization of COVID-19 testing technologies, a pivotal component needed to return to normal during this unprecedented global pandemic.

30 Apr 2020